"Lilly's phase 2 retatrutide results published in The New England Journal of Medicine show the investigational molecule achieved up to 17.5% mean weight reduction at 24 weeks in adults with obesity and overweight"
Additionally, the FDA has issued safety alerts about compounded or unapproved GLP-1 formulations, emphasizing that patients exposed to these off-label products face unpredictable and potentially serious side effects
While complaints about refunds and shipping exist, there are no signs of fraudulent activity
Myalgic encephalomyelitis/chronic fatigue syndrome: a comprehensive review
Due to its antioxidant properties, aloe vera also prevents tanning at bay
[DOI] [PMC free article] [PubMed] [Google Scholar] Suboticanec K, Folnegovi-Smalc V, Turcin R, Mestrovi B, Buzina R